About BIOLOGICAL MIMETICS, INC.
Biological Mimetics, Inc. (BMI) was formed in 1996 to commercialize innovative pharmaceutical products aimed at improving public health by combating resistant and emerging diseases in human and veterinary medicine. The company focuses on technologies such as IRT and FAST for vaccine development and diagnostics.
Development of vaccine platforms using IRT technologyCreation of rapid diagnostic tools like FAST using CRISPR and RPA amplificationCollaboration with academic institutions for technology development
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| PHASE II SBIR BIOLOGICAL MIMETICS, INC. AWARD | Department of Health and Human Services | $1.5M | |
| PHASE I SBIR BIOLOGICAL MIMETICS, INC. AWARD | Department of Health and Human Services | $300K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to BIOLOGICAL MIMETICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.